spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cerus  

 HSMN NewsFeed - 18 May 2023
Endogenex(TM) Appoints Christopher Sorli as Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 12 Jul 2022
Cerus Endovascular Names Stephen Griffin as Chief Executive Officer
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 21 Apr 2021
Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System(TM)
Devices Interventional Neurosurgery FDA
 HSMN NewsFeed - 29 Apr 2020
Cerus Endovascular Receives CE Mark Approval for its 021 Contour Neurovascular System(TM)
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 22 Apr 2020
Cerus Endovascular Receives CE Mark Approvals for its Neqstent(TM) Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 21 Feb 2020
Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
Devices Interventional Neurology Venture Capital FDA
 HSMN NewsFeed - 18 Feb 2020
Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System(TM), Designed to Treat Intracranial Aneurysms
Devices Interventional Radiology Regulatory
 HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2019
Acerus And Aytu Bioscience To Co-Promote NATESTO(R) In The United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Nov 2018
Cerus Endovascular Expands Intellectual Property Portfolio
Devices Interventional Neurology
 HSMN NewsFeed - 11 May 2018
Cerus Endovascular Promotes Stephen Griffin, PhD, to President
Devices Interventional Radiology Neurology Personnel
 HSMN NewsFeed - 31 Dec 2015
Acerus Announces Termination of NATESTO(TM) Agreement with Endo
Biopharmaceuticals Distribution
 HSMN NewsFeed - 13 Feb 2013
Cellerant Appoints William Reed, M.D., as Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 21 Jul 2011
Merz Aesthetics Announces FDA Approval Of XEOMIN(R) (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 20 Apr 2011
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 2 Mar 2010
Catalyst Biosciences Appoints William J. Dawson Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Aug 2009
Cerus' INTERCEPT Blood System for Platelets Receives Swiss Approval
Devices Regulatory
 HSMN NewsFeed - 14 May 2009
New Label Claim Expands Market for Cerus' INTERCEPT Blood System
Devices Regulatory
 HSMN NewsFeed - 2 Apr 2009
Jazz Pharmaceuticals, Inc. Announces Board of Directors and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2008
Cerus' INTERCEPT Blood System Receives CE Mark Label Expansion for Treatment of Previously Frozen Plasma
Devices Regulatory
 HSMN NewsFeed - 11 Jun 2008
Cerus Enters into Agreement to Supply INTERCEPT Platelet System to Largest Region of German Red Cross
Devices
 HSMN NewsFeed - 21 Apr 2008
Cerus Receives Label Expansion on CE Marks for Use of INTERCEPT Blood System
Devices Regulatory
 HSMN NewsFeed - 31 Mar 2008
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
Devices Personnel
 HSMN NewsFeed - 3 Mar 2008
Cerus Promotes Laurence M. Corash, M.D. to Senior Vice President and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 28 Jan 2008
Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2007
Cerus Announces Agreement to Supply the INTERCEPT Blood System for Platelets to French National Blood Service
Devices
 HSMN NewsFeed - 6 Mar 2007
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jan 2007
Cerus Announces French Regulatory Approval of the INTERCEPT Blood System for Plasma
Devices Regulatory
 HSMN NewsFeed - 21 Nov 2006
Cerus Corporation Announces European Regulatory Approval for the INTERCEPT Blood System for Plasma
Devices Regulatory
 HSMN NewsFeed - 28 Sep 2006
Cerus Strengthens European Management Team
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 19

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 19 additional stories matching:
Cerus
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.